Neuroscience Research Group (NEUROS)

Medicine & Life Sciences

1. Colombia 100%
2. Ocular Toxoplasmosis 79%
3. Systematic Reviews 41%
4. Uveitis 36%
5. Eye 33%
6. Toxoplasmosis 31%
7. Child 29%
8. Toxoplasma 26%
9. Epilepsy 24%
10. Pain Management 20%
11. Therapeutics 19%
12. Opioid Analgesics 19%
13. Latin America 19%
14. Pain 17%
15. Meta-Analysis 17%
16. Alzheimer Disease 17%
17. Down Syndrome 16%
18. Music 15%
19. Epidemiology 15%
20. Anterior Uveitis 15%
21. Attention Deficit Disorder with Hyperactivity 15%
22. Genes 15%
23. Multiple Sclerosis 15%
24. Sleep 14%
25. Population 14%
26. Eye Manifestations 14%
27. relacin 14%
28. Scleritis 13%
29. Iris 13%
30. Low Back Pain 12%
31. Moxifloxacin 12%
32. Seizures 12%
33. Learning 12%
34. Language 12%
35. Brain 11%
36. Vitamin B Complex 11%
37. Databases 11%
38. Neuralgia 11%
39. Neuronal Plasticity 11%
40. Diabetic Neuropathies 11%
41. Medicine 11%
42. Aptitude 10%
43. cyanocobalamin, pyridoxine, thiamine drug combination 10%
44. Coinfection 10%
45. Cross-Sectional Studies 10%
46. Health 10%
47. Astrocytes 9%
48. Public Health 9%
49. Safety 9%
50. Anticonvulsants 9%
51. Guidelines 9%
52. Executive Function 9%
53. Memory 8%
54. Tune Deafness 8%
55. Parasites 8%
56. Impulsive Behavior 8%
57. Macaca arctoides 8%
58. Consensus 8%
59. Referral and Consultation 8%
60. Cognition 8%
61. Chronic Pain 8%
62. Uveomeningoencephalitic Syndrome 8%
63. Neurology 7%
64. Animal Assisted Therapy 7%
65. Stroke 7%
66. Biomarkers 7%
67. South America 7%
68. Central Nervous System 7%
69. Inflammation 7%
70. Infections 7%
71. Intermediate Uveitis 7%
72. PubMed 7%
73. Incidence 7%
74. Benign Mucous Membrane Pemphigoid 7%
75. Peptides 7%
76. Dementia 7%
77. Hearing Loss 7%
78. History 7%
79. Cognitive Dysfunction 7%
80. Transillumination 7%
81. Eye Diseases 6%
82. Nervous System 6%
83. Hearing Tests 6%
84. Vision Disorders 6%
85. Polymerase Chain Reaction 6%
86. Activity Cycles 6%
87. Prefrontal Cortex 6%
88. Ophthalmologists 6%
89. Differential Diagnosis 6%
90. Antibodies 6%
91. Democratic Republic of the Congo 6%
92. Cannabinoids 6%
93. Costs and Cost Analysis 6%
94. Pharmaceutical Preparations 6%
95. HIV 6%
96. Pharmacology 6%
97. Status Epilepticus 6%
98. Ocular Tuberculosis 6%
99. Severe Acute Respiratory Syndrome 6%
100. Vitamin B 12 6%